Evidence map›Paper›PMID 31782026›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2020

Shiga toxin-producing Escherichia coli in household members of children with hemolytic uremic syndrome.

Laura Fernanda Alconcher, Marta Rivas, Lucas Ivan Lucarelli, Jimena Galavotti, Mabel Rizzo

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Therapeutic Antibodies Against Shiga Toxins: Trends and Perspectives.Frontiers in cellular and infection microbiology · 2022
    Review
  4. Detection of Shiga Toxin-ProducingFrontiers in endocrinology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Laura Fernanda AlconcherPediatric Nephrology Unit, Hospital Interzonal General Dr. Jose Penna, Bahía Blanca, Argentina. laura.alconcher.la@gmail.com.ORCID http://orcid.org/0000-0002-2130-0307
Marta RivasInstituto Nacional de Enfermedades Infecciosas, ANLIS "Dr. Carlos G. Malbrán", Buenos Aires, Argentina.
Lucas Ivan LucarelliPediatric Nephrology Unit, Hospital Interzonal General Dr. Jose Penna, Bahía Blanca, Argentina.
Jimena GalavottiMicrobiology Laboratory, Hospital Interzonal General Dr. Jose Penna, Bahía Blanca, Argentina.
Mabel RizzoMicrobiology Laboratory, Hospital Interzonal General Dr. Jose Penna, Bahía Blanca, Argentina.
Administración Nacional de Laboratorios e Institutos de Salud · ARCentro Científico Tecnológico - Bahía Blanca · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective is to establish the frequency of STEC infections in household contacts of HUS patients. We studied 292 household contacts of 82 HUS patients attended from 2010 to 2018. In HUS cases, diagnostic criteria were (1) isolation and characterization of STEC strains, (2) detection of free fecal Shiga toxin (FFStx), and (3) detection of anti-O serogroup-specific antibodies. Contacts were studied by screening of stx genes by polymerase chain reaction and/or STEC isolation from stool samples. Clonal relation of STEC strains was established by pulsed-field gel electrophoresis (PFGE). Frequencies of HUS patients without STEC isolation with STEC-positive contacts were determined. Serotypes and stx-genotypes in patients and contacts were analyzed. Thirty (36.6%) HUS patients had 36 STEC-positive contacts. Fourteen (38.8%) were children, 20 adults, and 2 dogs. One sibling developed HUS, 6 contacts had gastrointestinal symptoms, and the rest were asymptomatic. In 5 of 30 HUS patients, STEC infection could not be confirmed, and 2 cases were diagnosed only by FFStx detection. Of the remaining 23 HUS patients, 16 had E. coli O157 and 7 E. coli O145 infection. Serotype and/or stx-genotype concordance was established in 19 (83%) of 23 HUS patients and their contacts. Five HUS cases and their contacts studied by PFGE showed macrorestriction patterns with more than 90% similarity. Nearly one third of HUS patients had STEC-positive family contacts, and one third of them were children. Early identification is important to prevent ongoing contamination among family and institutional contacts and to facilitate prompt detection of HUS in STEC-positive contacts.

Indexed as

FamilyShiga-Toxigenic Escherichia coliAdolescentAdultAgedAge FactorsChildChild, PreschoolElectrophoresis, Gel, Pulsed-FieldFecesFemaleGenotypeHemolytic-Uremic SyndromeHumansMaleMiddle AgedShiga ToxinAsymptomatic carriersHouseholdHUSOutbreaksSecondary transmissionSTEC

Identifiers

PMID31782026
OpenAlexW2990405319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.